JPMorgan Chase & Co’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $53.6M | Sell |
|
|||||
2025
Q1 | $222M | Buy |
|
|||||
2024
Q4 | $101M | Sell |
|
|||||
2024
Q3 | $113M | Sell |
|
|||||
2024
Q2 | $132M | Sell |
|
|||||
2024
Q1 | $124M | Sell |
|
|||||
2023
Q4 | $140M | Sell |
|
|||||
2023
Q3 | $85.1M | Buy |
|
|||||
2023
Q2 | $102M | Buy |
|
|||||
2023
Q1 | $69.8M | Buy |
|
|||||
2022
Q4 | $63.4M | Sell |
|
|||||
2022
Q3 | $98.2M | Sell |
|
|||||
2022
Q2 | $87.1M | Buy |
|
|||||
2022
Q1 | $107M | Buy |
|
|||||
2021
Q4 | $176M | Buy |
|
|||||
2021
Q3 | $156M | Sell |
|
|||||
2021
Q2 | $138M | Buy |
|
|||||
2021
Q1 | $149M | Buy |
|
|||||
2020
Q4 | $168M | Buy |
|
|||||
2020
Q3 | $125M | Buy |
|
|||||
2020
Q2 | $87M | Buy |
|
|||||
2020
Q1 | $56.7M | Buy |
|
|||||
2019
Q4 | $9.12M | Sell |
|
|||||
2019
Q3 | $8.93M | Buy |
|
|||||
2019
Q2 | $10.4M | Buy |
|
|||||
2019
Q1 | $8.91M | Buy |
|
|||||
2018
Q4 | $4.27M | Buy |
|
|||||
2018
Q3 | $6.01M | Buy |
|
|||||
2018
Q2 | $4.64M | Buy |
|
|||||
2018
Q1 | $4.84M | Buy |
|
|||||
2017
Q4 | $1.58M | Buy |
|
|||||
2017
Q3 | $772K | Buy |
|
|||||
2017
Q2 | $535K | Sell |
|
|||||
2017
Q1 | $5.79M | Sell |
|
|||||
2016
Q4 | $4.68M | Buy |
|
|||||
2016
Q3 | $4.89M | Buy |
|
|||||
2016
Q2 | $3.23M | Buy |
|
|||||
2016
Q1 | $1.45M | Buy |
|
|||||
2015
Q4 | $2.09M | Sell |
|
|||||
2015
Q3 | $1.95M | Sell |
|
|||||
2015
Q2 | $6.94M | Buy |
|